(2) Although the findings of our study suggested a potential association between GAS5 and myocardial electrical remodeling, extensive studies are needed to verify its practical significance as a therapeutic target and biomarker for AF, given the fact that various targeted therapeutic approaches have been introduced but are severely limited by side effects or complications [40]. The gene discussed is GAS5; the disease is atrial fibrillation.